0,925  0,003  Cardiovascular analeptic
0,901  0,003  UDP-glucuronosyltransferase substrate
0,896  0,004  CYP2C9 substrate
0,869  0,002  Endometrios treatment
0,870  0,005  Teratogen
0,855  0,003  UGT1A6 substrate
0,854  0,003  NOS3 expression inhibitor
0,855  0,005  Embryotoxic
0,845  0,003  Sulfotransferase substrate
0,845  0,003  UGT1A9 substrate
0,845  0,004  Sensitization
0,831  0,005  Respiratory analeptic
0,832  0,008  CYP3A4 substrate
0,826  0,004  Cholesterol antagonist
0,815  0,002  UGT1A4 substrate
0,812  0,004  Analeptic
0,804  0,005  CYP1A2 substrate
0,803  0,006  Carcinogenic
0,809  0,014  Antiinflammatory
0,796  0,002  UGT2B1 substrate
0,797  0,006  Antihypercholesterolemic
0,791  0,003  Prostatic (benign) hyperplasia treatment
0,792  0,005  Prostate cancer treatment
0,784  0,002  Aromatase inhibitor
0,777  0,009  TNF expression inhibitor
0,757  0,002  UGT2B15 substrate
0,765  0,013  Antineoplastic (breast cancer)
0,734  0,002  Postmenopausal disorders treatment
0,733  0,002  Contraceptive
0,736  0,005  Bone diseases treatment
0,723  0,005  Antiosteoporotic
0,718  0,001  UGT2B4 substrate
0,731  0,026  Apoptosis agonist
0,706  0,004  Diuretic
0,709  0,007  CYP2C19 substrate
0,702  0,020  Transcription factor NF kappa B inhibitor
0,684  0,004  Hair growth stimulant
0,680  0,005  Hypoxia-inducible factor 1 alpha inhibitor
0,679  0,004  Antipruritic, allergic
0,666  0,005  UGT1A1 substrate
0,685  0,026  Caspase 9 stimulant
0,655  0,007  AR expression inhibitor
0,650  0,010  CTGF expression inhibitor
0,642  0,004  Anesthetic general
0,642  0,006  CYP2C19 inhibitor
0,639  0,003  Androgen antagonist
0,630  0,003  Interleukin 2 agonist
0,635  0,014  Aldehyde oxidase inhibitor
0,621  0,002  Contraceptive female
0,618  0,002  Lipocortins synthesis antagonist
0,612  0,002  Contraceptive male
0,608  0,002  Prostate disorders treatment
0,609  0,003  Estrogen agonist
0,614  0,010  NOS2 expression inhibitor
0,601  0,004  Antiacne
0,593  0,001  Glucose-6-phosphate dehydrogenase inhibitor
0,593  0,003  Psychosexual dysfunction treatment
0,588  0,002  UGT2B7 substrate
0,570  0,002  Androgen agonist
0,572  0,004  NOS3 expression enhancer
0,561  0,005  UGT1A3 substrate
0,548  0,003  Abortion inducer
0,547  0,005  Male reproductive disfunction treatment
0,551  0,011  Cardiodepressant
0,540  0,001  RNA-directed RNA polymerase stimulant
0,540  0,001  UGT2B10 substrate
0,543  0,005  Anesthetic
0,527  0,002  UGT2B9 substrate
0,524  0,001  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,543  0,021  Antineoplastic (ovarian cancer)
0,533  0,017  Proliferative diseases treatment
0,539  0,023  Immunosuppressant
0,514  0,002  Estradiol 17 beta-dehydrogenase inhibitor
0,511  0,003  Cushing's syndrome treatment
0,512  0,008  Interleukin agonist
0,504  0,002  Antipruritic, non-allergic
0,499  0,002  Aldosterone antagonist
0,494  0,002  Progesterone antagonist
0,489  0,001  5-Alpha-reductase 1 inhibitor
0,491  0,004  Estrogen antagonist
0,488  0,003  Menstruation disorders treatment
0,485  0,004  Sodium/bile acid cotransporter inhibitor
0,491  0,012  Psychostimulant
0,483  0,005  Muscular dystrophy treatment
0,484  0,007  Interferon gamma antagonist
0,497  0,019  Chemopreventive
0,481  0,005  Glutathione S-transferase substrate
0,486  0,010  Antineoplastic (liver cancer)
0,477  0,003  Mineralocorticoid receptor antagonist
0,498  0,025  CYP2D6 substrate
0,491  0,020  Antineoplastic (glioma)
0,493  0,025  Antineoplastic (melanoma)
0,491  0,026  Cytotoxic
0,486  0,023  Antineoplastic (pancreatic cancer)
0,455  0,004  Estrogen receptor alpha antagonist
0,464  0,019  Nitric oxide antagonist
0,446  0,004  Antiinfertility, female
0,437  0,001  5-Alpha-reductase 2 inhibitor
0,439  0,005  Antifungal enhancer
0,450  0,020  CYP3A4 inhibitor
0,431  0,003  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,446  0,021  Antineoplastic (glioblastoma multiforme)
0,423  0,002  5-Alpha-reductase inhibitor
0,430  0,010  Melanin inhibitor
0,444  0,032  Hepatic disorders treatment
0,415  0,003  Alcohol dehydrogenase substrate
0,409  0,004  Cholesterol synthesis inhibitor
0,411  0,008  Antialcoholic
0,396  0,007  Antipruritic
0,392  0,003  Estrogen receptor beta agonist
0,417  0,033  Antineoplastic (cervical cancer)
0,426  0,043  Antiallergic
0,415  0,034  Apoptosis antagonist
0,382  0,003  Estrogen receptor alpha agonist
0,381  0,007  Toxic, respiratory center
0,405  0,033  Chemoprotective
0,372  0,003  Growth stimulant
0,368  0,002  Glucocorticoid antagonist
0,358  0,002  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,359  0,003  SULT1A1 substrate
0,360  0,004  Estrogen receptor beta antagonist
0,382  0,028  Antineoplastic (renal cancer)
0,365  0,014  Carcinogenic, group 3
0,352  0,004  Anticataract
0,340  0,001  UGT2B11 substrate
0,403  0,064  Antineoplastic (lung cancer)
0,359  0,022  Antineoplastic (sarcoma)
0,338  0,001  Anabolic
0,382  0,047  ICAM1 expression inhibitor
0,337  0,004  Posttraumatic stress disorder treatment
0,354  0,024  Sedative
0,358  0,035  Mutagenic
0,333  0,011  Neurotrophic factor enhancer
0,357  0,037  Antihypoxic
0,323  0,005  Phobic disorders treatment
0,328  0,010  Growth factor agonist
0,317  0,005  Farnesoid X receptor antagonist
0,306  0,002  Arachidonic acid antagonist
0,359  0,056  Caspase 3 stimulant
0,307  0,006  Antieczematic
0,324  0,025  P-glycoprotein inhibitor
0,300  0,004  Pregnane X receptor agonist
0,369  0,074  Antileukemic
0,302  0,008  LDLR expression enhancer
0,320  0,028  Muscle relaxant
0,354  0,063  Immunostimulant
0,295  0,005  Hedgehog signaling inhibitor
0,292  0,003  Premenstrual syndrome treatment
0,326  0,040  Heart failure treatment
0,285  0,005  VEGF expression inhibitor
0,325  0,046  Cytostatic
0,306  0,028  Hepatoprotectant
0,301  0,023  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,277  0,001  Postcoital contraceptive
0,314  0,039  GST M1-1 substrate
0,276  0,002  Glycine receptor antagonist
0,316  0,043  Angiogenesis stimulant
0,329  0,057  Radioprotector
0,332  0,061  5 Hydroxytryptamine release stimulant
0,277  0,007  Antineoplastic, alkylator
0,271  0,002  Progesterone agonist
0,282  0,014  Aldehyde dehydrogenase inhibitor
0,320  0,053  Antineoplastic (endocrine cancer)
0,275  0,011  Autism spectrum disorders treatment
0,266  0,016  Antihyperlipoproteinemic
0,299  0,049  Acute neurologic disorders treatment
0,299  0,050  Myocardial infarction treatment
0,268  0,022  Bone formation stimulant
0,331  0,087  Stroke treatment
0,247  0,002  Estradiol 17 beta-dehydrogenase 1 inhibitor
0,284  0,040  Antineoplastic enhancer
0,284  0,041  Antiparkinsonian, rigidity relieving
0,270  0,028  Antianorexic
0,270  0,033  Eye irritation, high
0,272  0,038  Antiviral (Influenza)
0,292  0,060  DNA damaging
0,248  0,017  DNA polymerase I inhibitor
0,306  0,076  Antineoplastic (brain cancer)
0,249  0,020  Age-related macular degeneration treatment
0,291  0,065  Antioxidant
0,324  0,099  CYP2C9 inhibitor
0,251  0,029  Skeletal muscle relaxant
0,225  0,003  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,248  0,025  Antiviral (Influenza A)
0,257  0,036  Antimutagenic
0,266  0,045  Antihypotensive
0,232  0,013  Microtubule formation inhibitor
0,272  0,056  Gastrin inhibitor
0,275  0,060  5 Hydroxytryptamine uptake stimulant
0,287  0,072  FMO3 substrate
0,230  0,016  Neurotrophic factor
0,209  0,002  Estrone sulfatase inhibitor
0,213  0,008  Actinic keratosis treatment
0,285  0,082  Antineoplastic (osteosarcoma)
0,208  0,006  Tocolytic
0,203  0,003  Antihyperaldosteronism
0,231  0,032  Protein kinase stimulant
0,208  0,011  Interleukin 8 antagonist
0,267  0,072  Cardiotonic
0,195  0,004  Glycine receptor agonist
0,272  0,083  Antineoplastic (multiple myeloma)
0,205  0,020  Carcinogenic, group 2B
0,239  0,053  VCAM1 expression inhibitor
0,217  0,032  Skin irritative effect
0,186  0,003  Hypogonadism treatment
0,213  0,030  Genotoxic
0,202  0,025  Adenylate cyclase inhibitor
0,184  0,008  CDC25A inhibitor
0,209  0,038  Lipid peroxidase inhibitor
0,180  0,010  Keratolytic
0,187  0,020  Choleretic
0,249  0,084  Amyotrophic lateral sclerosis treatment
0,221  0,057  Pneumotoxic
0,167  0,004  Na+ K+ transporting ATPase inhibitor
0,201  0,040  Interleukin 6 antagonist
0,203  0,043  Amylase inhibitor
0,240  0,082  Antipyretic
0,183  0,028  Retinoprotector
0,250  0,096  Cardioprotectant
0,160  0,006  Bile acid receptor antagonist
0,196  0,044  Antirickettsial
0,178  0,027  Adenylate cyclase stimulant
0,222  0,072  RNA-directed DNA polymerase inhibitor
0,152  0,002  Lipocortins synthesis agonist
0,164  0,014  ABCA1 expression enhancer
0,271  0,123  Calcium channel activator
0,155  0,014  SULT1E1 substrate
0,177  0,039  Anesthetic local
0,140  0,002  Glucocorticoid agonist
0,141  0,003  SULT2A1 substrate
0,223  0,087  Antiprotozoal (Leishmania)
0,197  0,061  Diabetic retinopathy treatment
0,187  0,054  Phospholipase C inhibitor
0,241  0,107  Antineoplastic (colorectal cancer)
0,163  0,031  Coagulant
0,135  0,002  Pregnane X receptor antagonist
0,167  0,035  Antihemorrhagic
0,228  0,098  Flavin-containing monooxygenase substrate
0,152  0,021  Prolactin inhibitor
0,220  0,095  Vascular (periferal) disease treatment
0,133  0,008  Anticholelithogenic
0,220  0,095  DNA synthesis inhibitor
0,257  0,134  Inflammatory Bowel disease treatment
0,227  0,105  Transcription factor STAT inhibitor
0,139  0,019  Inducible nitric-oxide synthase inhibitor
0,120  0,000  Transcortin receptor antagonist
0,226  0,107  Antineoplastic (colon cancer)
0,130  0,011  GABA receptor antagonist
0,140  0,023  Acetylcholine release stimulant
0,143  0,033  AMP-activated protein kinase stimulant
0,111  0,002  Corticosteroid-like
0,113  0,005  Heme oxygenase stimulant
0,116  0,012  Estrogen-related receptor beta agonist
0,259  0,157  15-Lipoxygenase inhibitor
0,227  0,126  Antifungal
0,240  0,139  FMO1 substrate
0,147  0,048  Monophenol monooxygenase inhibitor
0,145  0,049  Alkylator
0,110  0,014  GABA A receptor antagonist
0,155  0,060  SULT1A3 substrate
0,111  0,017  Narcotic antagonist
0,177  0,084  Platelet adhesion inhibitor
0,200  0,109  Tumour necrosis factor alpha release inhibitor
0,127  0,038  Dementia treatment
0,214  0,124  Antiepileptic
0,160  0,071  Antiviral (Herpes)
0,126  0,038  Toll-Like receptor 4 antagonist
0,156  0,069  Acetylcholine M1 receptor antagonist
0,105  0,018  Dysmenorrhea treatment
0,116  0,029  Ornithine decarboxylase inhibitor
0,123  0,037  Vascular dementia treatment
0,090  0,006  Liver X receptor alpha agonist
0,144  0,060  Ca2+-transporting ATPase inhibitor
0,245  0,162  Antiobesity
0,115  0,032  Acetylcholine nicotinic antagonist
0,237  0,155  Ulceration
0,086  0,008  Anesthetic inhalation
0,199  0,123  Lipoprotein disorders treatment
0,152  0,077  Cyclin-dependent kinase 8 inhibitor
0,084  0,009  Liver X receptor agonist
0,214  0,139  Metabolic disease treatment
0,087  0,014  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,188  0,115  Antineoplastic (non-small cell lung cancer)
0,097  0,027  SULT1A2 substrate
0,084  0,014  Andropause treatment
0,094  0,024  Beta tubulin antagonist
0,092  0,024  Female sexual dysfunction treatment
0,104  0,037  Glutamate release inhibitor
0,179  0,114  Antineoplastic (lymphoma)
0,171  0,107  Antihypertriglyceridemic
0,145  0,082  Movement disorders treatment
0,183  0,123  Antidiabetic symptomatic
0,177  0,117  Free radical scavenger
0,214  0,155  Antihypertensive
0,096  0,039  Antiprotozoal activity enhancer
0,128  0,073  Tubulin antagonist
0,128  0,074  Liver cirrhosis treatment
0,128  0,075  Antiprotozoal (Trichomonas)
0,067  0,014  Adenylate cyclase 1 inhibitor
0,270  0,218  Antineoplastic (solid tumors)
0,068  0,016  Potassium channel Kv1.3 blocker
0,052  0,002  Progesterone receptor A antagonist
0,194  0,146  Radiosensitizer
0,057  0,009  Liver X receptor beta agonist
0,085  0,038  Lipase inhibitor
0,084  0,038  Antidote, organophosphates
0,191  0,146  Transcription factor STAT3 inhibitor
0,048  0,003  Hedgehog signaling activator
0,214  0,172  GST A substrate
0,163  0,124  Hypolipemic
0,158  0,119  CYP2B6 inhibitor
0,049  0,011  Cholesterol absorption inhibitor
0,049  0,012  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,279  0,243  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,103  0,068  GST T1-1 substrate
0,035  0,001  3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor
0,120  0,086  Skin whitener
0,054  0,022  Microtubule stabilization
0,147  0,117  Succinate dehydrogenase inhibitor
0,048  0,018  GABA uptake inhibitor
0,110  0,081  Transcription factor STAT6 inhibitor
0,130  0,102  Sigma receptor agonist
0,084  0,056  GABA A receptor agonist
0,154  0,128  Antiparasitic
0,082  0,056  Antineoplastic antibiotic
0,215  0,189  GABA C receptor rho-3 antagonist
0,067  0,043  Uterine relaxant
0,043  0,020  Farnesoid X receptor agonist
0,047  0,027  Parathyroid hormone antagonist
0,024  0,005  Telomerase stimulant
0,026  0,007  Progesterone receptor B antagonist
0,062  0,043  Antimycoplasmal
0,138  0,121  Hearing loss treatment
0,089  0,072  Creatine kinase inhibitor
0,026  0,009  Vitamin D receptor antagonist
0,108  0,092  Antiprotozoal (Amoeba)
0,139  0,124  Antihelmintic
0,053  0,038  Alpha tubulin antagonist
0,097  0,082  DOPA decarboxylase inhibitor
0,062  0,049  Calcium channel P-type blocker
0,114  0,100  Antineoplastic (carcinoma)
0,183  0,170  Tyrosine 3 hydroxylase inhibitor
0,102  0,090  Acetylcholine antagonist
0,080  0,069  Transcription factor NF kappa B stimulant
0,113  0,102  Antiparkinsonian, tremor relieving
0,082  0,071  Antidote, mercury
0,042  0,031  Heme oxygenase inhibitor
0,094  0,084  GABA receptor agonist
0,103  0,092  Cholinergic antagonist
0,029  0,021  Liver X receptor alpha antagonist
0,017  0,009  NMDA receptor phencyclidine site antagonist
0,077  0,072  Sleep apnea treatment
0,106  0,101  Antismoking
0,037  0,032  Dopamine D5 agonist
0,076  0,071  Antineoplastic alkaloid
0,073  0,068  Carbonic anhydrase VI inhibitor
0,085  0,082  Lanosterol 14 alpha demethylase inhibitor
0,016  0,013  Vitamin D receptor agonist
0,014  0,013  4-Hydroxyphenylpyruvate dioxygenase inhibitor
0,094  0,093  Antitussive
0,062  0,061  Glutamate (mGluR6) antagonist
0,040  0,039  Alpha 1L adrenoreceptor agonist
0,061  0,061  Glutamate (mGluR7) antagonist

